Savior Lifetec Corporation (TPEX:4167)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.95
-0.15 (-0.79%)
At close: Feb 26, 2026
-9.11%
Market Cap 5.88B
Revenue (ttm) 1.16B
Net Income (ttm) 495.76M
Shares Out 310.44M
EPS (ttm) 1.57
PE Ratio 12.10
Forward PE n/a
Dividend 0.40 (2.11%)
Ex-Dividend Date Jul 14, 2025
Volume 781,600
Average Volume 2,232,990
Open 19.10
Previous Close 19.10
Day's Range 18.90 - 19.15
52-Week Range 14.35 - 22.60
Beta 0.38
RSI 42.55
Earnings Date Mar 13, 2026

About Savior Lifetec

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 384
Stock Exchange Taipei Exchange
Ticker Symbol 4167
Full Company Profile

Financial Performance

In 2024, Savior Lifetec's revenue was 1.22 billion, an increase of 15.91% compared to the previous year's 1.05 billion. Earnings were 182.38 million, an increase of 507.33%.

Financial Statements

News

There is no news available yet.